Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Nateglinide: an insulin secretagogue with significant advantages over other drugs in its class

June 22, 1999

DPP-IV inhibitor isoleucine thiazolidide is effective in rat model of type II diabetes

June 22, 1999

U.S.-Mexican team identifies FL-104, a potent and selective ERalpha ligand

June 22, 1999

New integrin receptor antagonists synthesized at DuPont

June 22, 1999

New product for anemia in hemodialysis patients now available in U.S.

June 22, 1999

NN-304 is a safe and predictable insulin analogue in human studies

June 22, 1999

New insulin preparation with improved stability for delivery via implanted pump

June 22, 1999

News from ADA: antidiabetic efficacy of the ingredients of an animal prostate extract

June 22, 1999

Role of pyruvate dehydrogenase in diabetes

June 22, 1999

Ipamorelin exerts potent GH secretagogue activity in pig fetuses

June 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...